{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:46:42Z","timestamp":1791521202406,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bbi.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T19:43:39Z","timestamp":1337024619000},"page":"830-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["A systematic review of the association between immunogenomic markers and cancer-related fatigue"],"prefix":"10.1016","volume":"26","author":[{"given":"L.N.","family":"Saligan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2012.05.004_b0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1099800403259500","article-title":"Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: a pilot study","volume":"5","author":"Ahlberg","year":"2004","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.bbi.2012.05.004_b0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejca.2008.09.010","article-title":"A comparison of the characteristics of disease-free cancer survivors with or without cancer-related fatigue syndrome","volume":"45","author":"Alexander","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1099800409333871","article-title":"Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue","volume":"11","author":"Aouizerat","year":"2009","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.bbi.2012.05.004_b0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor\u2013host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbi.2012.05.004_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000096887","article-title":"Permeability of the blood\u2013brain barrier to soluble cytokine receptors","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2012.05.004_b0030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.6004\/jnccn.2010.0067","article-title":"Cancer-related fatigue","volume":"8","author":"Berger","year":"2010","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.bbi.2012.05.004_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1188\/09.ONF.209-216","article-title":"The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma","volume":"36","author":"Booker","year":"2009","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.bbi.2012.05.004_b0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2012.05.004_b0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/djg0019","article-title":"T-cell homeostasis in breast cancer survivors with persistent fatigue","volume":"95","author":"Bower","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbi.2012.05.004_b0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbi.2006.08.001","article-title":"Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids","volume":"21","author":"Bower","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.05.004_b0055","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-08-2584","article-title":"Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer","volume":"15","author":"Bower","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbi.2010.09.010","article-title":"Fatigue and gene expression in human leukocytes: increased NF-\u03baB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue","volume":"25","author":"Bower","year":"2011","journal-title":"Brain Behav. Immune."},{"key":"10.1016\/j.bbi.2012.05.004_b0065","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2011.36.1154","article-title":"Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?","volume":"29","author":"Bower","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2012.05.004_b0070","doi-asserted-by":"crossref","unstructured":"Cella, D., Davis, K., Breitbart, W., Curt, G., Fatigue Coalition, 2001. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J. Clin. Oncol. 19, 3385\u20133391.","DOI":"10.1200\/JCO.2001.19.14.3385"},{"key":"10.1016\/j.bbi.2012.05.004_b0075","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1158\/1078-0432.CCR-05-2398","article-title":"Inflammatory biomarkers for persistent fatigue in breast cancer survivors","volume":"12","author":"Collado-Hidalgo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbi.2008.05.009","article-title":"Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings","volume":"22","author":"Collado-Hidalgo","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.05.004_b0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1634\/theoncologist.5-5-353","article-title":"Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition","volume":"5","author":"Curt","year":"2000","journal-title":"Oncologists"},{"key":"10.1016\/j.bbi.2012.05.004_b0090","article-title":"Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors","author":"Fernandez-de-las-Penas","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbi.2012.05.004_b0095","doi-asserted-by":"crossref","first-page":"976241","DOI":"10.1155\/2012\/976241","article-title":"The local inflammatory responses to infection of the peritoneal cavity in humans: their regulation by cytokines, macrophages, and other leukocytes","volume":"2012","author":"Fieren","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2012.05.004_b0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0167-5699(88)91203-0","article-title":"Neopterin as a marker for activated cell-mediated immunity: application in HIV infection","volume":"9","author":"Fuchs","year":"1988","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbi.2012.05.004_b0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2012.01.061","article-title":"Central nervous system inflammation in disease related conditions: mechanistic prospects","volume":"1446","author":"Fung","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0360-3016(01)01657-1","article-title":"Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer","volume":"51","author":"Geinitz","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbi.2012.05.004_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpainsymman.2007.03.009","article-title":"Plasma interleukin-6 and fatigue in terminally ill cancer patients","volume":"35","author":"Inagaki","year":"2008","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2012.05.004_b0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-381326-8.00010-7","article-title":"Catechol-O-methyltransferase and pain","volume":"95","author":"Kambur","year":"2010","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbi.2012.05.004_b0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.111.183053","article-title":"Small molecular positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH","volume":"340","author":"Kaszas","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2012.05.004_b0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11920-011-0251-x","article-title":"Gene\u2013environment interaction in major depression and antidepressant treatment response","volume":"14","author":"Keers","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbi.2012.05.004_b0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.20052","article-title":"Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli","volume":"472","author":"Konsman","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbi.2012.05.004_b0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0269216311406991","article-title":"The relationship between interleukin-6, tumor necrosis factor-{alpha}, and fatigue in terminally ill cancer patients","volume":"26","author":"Kwak","year":"2012","journal-title":"Palliat. Med."},{"key":"10.1016\/j.bbi.2012.05.004_b0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/tpj.2009.27","article-title":"Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors","volume":"9","author":"Landmark-H\u00f8yvik","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bbi.2012.05.004_b0150","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","article-title":"Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids","volume":"47","author":"Laugsand","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smim.2010.03.001","article-title":"Chemotherapy and radiotherapy: cryptic anticancer vaccines","volume":"22","author":"Ma","year":"2010","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbi.2012.05.004_b0160","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0165","unstructured":"Miakowski, C.A., 2002. Assessment and management of cancer-related fatigue. In: Berger, A.M. (Ed.), Principles and Practice of Palliative Care and Supportive Oncology. Lippincott William & Wilkins, Philadelphia, PA, p. 143."},{"key":"10.1016\/j.bbi.2012.05.004_b0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jpainsymman.2009.12.006","article-title":"Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers","volume":"40","author":"Miaskowski","year":"2010","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2012.05.004_b0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/07357900009012171","article-title":"Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist","volume":"18","author":"Miller","year":"2000","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bbi.2012.05.004_b0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsycho.2004.11.007","article-title":"The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer","volume":"69","author":"Mills","year":"2005","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.bbi.2012.05.004_b0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/annonc\/mdn537","article-title":"A systematic review of the scales used for the measurement of cancer-related fatigue (CRF)","volume":"20","author":"Minton","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbi.2012.05.004_b0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpainsymman.2011.03.025","article-title":"Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set","volume":"43","author":"Minton","year":"2012","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2012.05.004_b0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jpsychores.2003.12.006","article-title":"Evaluation of four highly cited energy and fatigue mood measures","volume":"57","author":"O\u2019Connor","year":"2004","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0885-3924(99)00138-4","article-title":"Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients","volume":"19","author":"Okuyama","year":"2000","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2012.05.004_b0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/104973202129120160","article-title":"Evolving routines: preventing fatigue associated with lung and colorectal cancer","volume":"12","author":"Olson","year":"2002","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpsychores.2011.04.003","article-title":"Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors","volume":"71","author":"Orre","year":"2011","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0215","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbi.2009.04.003","article-title":"Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue","volume":"23","author":"Orre","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.05.004_b0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1478951509000273","article-title":"Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis","volume":"7","author":"Paddison","year":"2009","journal-title":"Palliat. Support Care"},{"key":"10.1016\/j.bbi.2012.05.004_b0225","first-page":"539","article-title":"Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia","volume":"17","author":"Panju","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0230","first-page":"269","article-title":"The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumour progression","volume":"23","author":"Pantschenko","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbi.2012.05.004_b0235","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.25255","article-title":"Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors","volume":"116","author":"Rausch","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0320","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bbi.2011.04.001","article-title":"Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway","volume":"25","author":"Reinertsen","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.05.004_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2009.11.002","article-title":"Lymphocytes in cancer development: polarization towards pro-tumor immunity","volume":"21","author":"Ruffell","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbi.2012.05.004_b0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbi.2012.05.004_b0255","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbi.2012.05.004_b0260","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbi.2012.05.004_b0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.bjc.6600466","article-title":"The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer","volume":"87","author":"Scott","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-5793(02)02643-1","article-title":"Endothelial Rho signaling is required for monocyte transendothelial migration","volume":"517","author":"Strey","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbi.2012.05.004_b0275","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.ejca.2010.03.026","article-title":"Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL","volume":"46","author":"Vallance","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbi.2012.05.004_b0280","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.NCC.0000305704.84164.54","article-title":"Predictors of cancer-related fatigue in women with breast cancer before, during, and after adjuvant therapy","volume":"31","author":"Von Ah","year":"2008","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.bbi.2012.05.004_b0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15476910903405528","article-title":"Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential","volume":"7","author":"Voronov","year":"2010","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.bbi.2012.05.004_b0290","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/erp.11.44","article-title":"Cancer-related fatigue: prevalence, assessment, and treatment strategies","volume":"11","author":"Weis","year":"2011","journal-title":"Expert. Rev. Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpainsymman.2007.08.019","article-title":"The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures","volume":"37","author":"Whitehead","year":"2009","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2012.05.004_b0300","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaci.2009.09.045","article-title":"Immune responses to malignancies","volume":"125","author":"Whiteside","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbi.2012.05.004_b0305","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbi.2012.05.004_b0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/0-387-26283-0_5","article-title":"The role of immune cells in the tumor microenvironment","volume":"130","author":"Whiteside","year":"2006","journal-title":"Cancer Treat Res."},{"key":"10.1016\/j.bbi.2012.05.004_b0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijrobp.2003.10.008","article-title":"Fatigue during breast radiotherapy and its relationship to biological factors","volume":"59","author":"Wratten","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159112001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159112001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:29:54Z","timestamp":1760167794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159112001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0889159112001110"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2012.05.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the association between immunogenomic markers and cancer-related fatigue","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2012.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}